Resona Asset Management’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.1M Sell
89,041
-4,575
-5% -$951K 0.1% 182
2026
Q1
$19.7M Sell
93,616
-2,153
-2% -$464K 0.1% 196
2025
Q4
$19.7M Sell
95,769
-6,539
-6% -$1.23M 0.09% 191
2025
Q3
$16M Sell
102,308
-5,890
-5% -$910K 0.08% 241
2025
Q2
$18.2M Buy
108,198
+4,345
+4% +$645K 0.09% 209
2025
Q1
$14.3M Buy
103,853
+4,904
+5% +$625K 0.08% 229
2024
Q4
$11.7M Buy
98,949
+2,883
+3% +$337K 0.07% 252
2024
Q3
$10.6M Sell
96,066
-3,534
-4% -$369K 0.06% 287
2024
Q2
$9.81M Buy
99,600
+2,642
+3% +$269K 0.06% 292
2024
Q1
$10.8M Buy
+96,958
New +$10.5M 0.06% 292

Other funds holding CAH

Resona Asset Management's CAH Position: Q2 2026 in Review

Resona Asset Management reduced its Cardinal Health (CAH) stake by 4.9% in Q2 2026, selling an estimated $951K and leaving 89,041 shares worth $21.1M. The position accounts for 0.1% of the portfolio, ranked #182.

Resona Asset Management first reported a position in CAH in Q1 2024 and has held it in 10 quarters since. 1,490 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Resona Asset Management held 89,041 shares of Cardinal Health worth $21.1M as of Q2 2026.
  • Resona Asset Management sold 4,575 Cardinal Health shares in Q2 2026, an estimated $951K.
  • Cardinal Health made up 0.1% of Resona Asset Management's portfolio in Q2 2026, its #182 holding.
  • Resona Asset Management first reported a position in Cardinal Health in Q1 2024 and has held it in 10 quarters since.
  • 1,490 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Resona Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.